Previously, a number of biomarkers have been identified to reveal the potential mechanisms of HTN, such as β2-microglobulin (β2-MG), transforming growth factor-β (TGF-β) and periostin [5, 6]. The gene discussed is TGFB1; the disease is hypertensive disorder.